妊娠高血压

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92.

• 摘要

Vigil-De Gracia P, Lasso M, Ruiz E, et al; HYLA treatment study. Severe hypertension in pregnancy: hydralazine or labetalol: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):157-62.

• 摘要

1.  Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92.

• 摘要

2.  Dolea C, Abou Zahr C; World Health Organization. Global burden of hypertensive disorders of pregnancy in the year 2000. July 2003 [internet publication].

• 全文

3.  Gregg AR. Hypertension in pregnancy. Obstet Gynecol Clin North Am. 2004 Jun;31(2):223-41;v.

• 摘要

4.  Koonin LM, MacKay AP, Berg CJ, et al. Pregnancy-related mortality surveillance - United States, 1987-1990. MMWR CDC Surveill Summ. 1997 Aug 8;46(4):17-36.

• 全文
• 摘要

5.  American Congress of Obstetrics and Gynecology (ACOG) Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. 2013 [internet publication].

• 全文

6.  James PR, Nelson-Piercy C. Management of hypertension before, during, and after pregnancy. Heart. 2004;90:1499-1504.

• 全文
• 摘要

7.  Department of Health. NHS maternity statistics, England: 1998-99 to 2000-01. February 2007. http://www.dh.gov.uk/ (last accessed 8 August 2016).

• 全文

8.  Committee on Technical Bulletins of the American Congress of Obstetricians and Gynecologists. ACOG technical bulletin. Hypertension in pregnancy. Number 219 - January 1996. Int J Gynaecol Obstet. 1996;53:175-183.

• 摘要

9.  Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in severe preeclampsia. Am J Obstet Gynecol. 2002;186:66-71.

• 摘要

10.  Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000 Jan;95(1):24-8.

• 摘要

11.  Knuist M, Bonsel GJ, Zondervan HA, et al. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet. 1998 May;61(2):127-33.

• 摘要

12.  Hnat MD, Sibai BM, Caritis S, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002 Mar;186(3):422-6. [Erratum in: Am J Obstet Gynecol. 2003 Jul;189(1):244.]

• 摘要

13.  Bryant AS, Seely EW, Cohen A, et al. Patterns of pregnancy-related hypertension in black and white women. Hypertens Pregnancy. 2005;24(3):281-90.

• 摘要

14.  Tanaka M, Jaamaa G, Kaiser M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health. 2007 Jan;97(1):163-70.

• 全文
• 摘要

15.  Luo ZC, Simonet F, An N, et al. Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies. Obstet Gynecol. 2006 Nov;108(5):1138-44.

• 全文
• 摘要

16.  Innes KE, Wimsatt JH, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol. 2001;97:905-910.

• 全文
• 摘要

17.  Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancies. Crit Care Med. 2005 Oct;33(suppl 10):S307-12.

• 摘要

18.  Wolf M, Sandler L, Jimenez-Kimble R, et al. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension. 2002 Dec;40(6):886-91.

• 全文
• 摘要

19.  Lombardi DG, Barton JR, O'Brien JM, et al. Does an obese prepregnancy body mass index influence outcome in pregnancies complicated by mild gestational hypertension remote from term? Am J Obstet Gynecol. 2005 May;192(5):1472-4.

• 摘要

20.  Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997 Nov;177(5):1003-10.

• 摘要

21.  Michlin R, Oettinger M, Odeh M, et al. Maternal obesity and pregnancy outcome. Isr Med Assoc J. 2000 Jan;2(1):10-3.

• 全文
• 摘要

22.  Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):642-8.

• 摘要

23.  Rasmussen S, Irgens LM. Pregnancy-induced hypertension in women who were born small. Hypertension. 2007 Apr;49(4):806-12.

• 全文
• 摘要

24.  Bismuth E, Bouche C, Caliman C, et al. Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]). Diabetes Metab. 2012 Jun;38(3):205-16.

• 摘要

25.  Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar;29(3):286-92.

• 摘要

26.  Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007 Aug;114(8):933-43.

• 全文
• 摘要

27.  Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health. 2011 Apr 13;11(suppl 3):S18.

• 全文
• 摘要

28.  Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health. 2011 Apr 13;11(suppl 3):S8.

• 全文
• 摘要

29.  Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol. 2012 Jul;26(suppl 1):138-52.

• 全文
• 摘要

30.  Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;(6):CD001059.

• 全文
• 摘要

31.  Lopez-Torres E, Doblas PA, del Valle VG, et al. Clinical evaluation of omega-3 fatty acids on pregnancy, breast feeding and infant development [in Spanish]. Clin Invest Ginecol Obstet. 2007;34:100-5.

• 全文

32.  Horvath A, Koletzko B, Szajewska H, et al. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr. 2007 Aug;98(2):253-9.

• 全文
• 摘要

33.  Bujold E, Morency AM, Roberge S, et al. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009 Sep;31(9):818-26.

• 摘要

34.  Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007 May 26;369(9575):1791-8.

• 摘要

35.  Ota E, Mori R, Middleton P, et al. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev. 2015;(2):CD000230.

• 全文
• 摘要

36.  Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010 Apr 8;362(14):1282-91.

• 全文
• 摘要

37.  Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007 Jun;28(12):1462-536.

• 全文
• 摘要

38.  Bergel E, Carroli G, Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev. 2002;(2):CD001231.

• 全文
• 摘要

39.  Brown MA, Roberts LM, Mackenzie C, et al. A prospective randomized study of automated versus mercury blood pressure recordings in hypertensive pregnancy (PRAM Study). Hypertens Pregnancy. 2012;31(1):107-19.

• 摘要

40.  Hillier TA, Vesco KK, Pedula KL, et al. Screening for gestational diabetes mellitus: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008 May 20;148(10):766-75.

• 全文
• 摘要

41.  Broekhuijsen K, van Baaren GJ, van Pampus MG, et al; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2492-501.

• 摘要

42.  van Baaren GJ, Broekhuijsen K2, van Pampus MG, et al. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II). BJOG. 2017 Feb;124(3):453-61.

• 摘要

43.  Cluver C, Novikova N, Koopmans CM, et al. Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. Cochrane Database Syst Rev. 2017;(1):CD009273.

• 全文
• 摘要

44.  Dowswell T, Middleton P, Weeks A. Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database Syst Rev. 2009;(4):CD001803.

• 全文
• 摘要

45.  Kiel DW, Dodson EA, Artal R, et al. Gestational weight gain and pregnancy outcomes in obese women: how much is enough? Obstet Gynecol. 2007 Oct;110(4):752-8.

• 摘要

46.  Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;(2):CD002252.

• 全文
• 摘要

47.  Vigil-De Gracia P, Lasso M, Ruiz E, et al; HYLA treatment study. Severe hypertension in pregnancy: hydralazine or labetalol: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):157-62.

• 摘要

48.  Khan K, Zamora J, Lamont RF, et al. Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis. J Matern Fetal Neonatal Med. 2010 Sep;23(9):1030-8.

• 摘要

49.  Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2003;(3):CD002863.

• 全文
• 摘要

50.  Churchill D, Beevers GD, Meher S, et al. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007;(1):CD004451.

• 全文
• 摘要

51.  Nabhan AF, Elsedawy MM. Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev. 2011;(7):CD006907.

• 全文
• 摘要

52.  Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015 Jan 29;372(5):407-17.

• 全文
• 摘要

53.  Raheem IA, Saaid R, Omar SZ, et al. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2012 Jan;119(1):78-85.

• 全文
• 摘要

54.  Lin JH, Yang YK, Liu H, et al. Effect of antioxidants on amelioration of high-risk factors inducing hypertensive disorders in pregnancy. Chin Med J (Engl). 2010 Sep;123(18):2548-54.

• 摘要

55.  Rahimi R, Nikfar S, Rezaie A, et al. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens Pregnancy. 2009 Aug;28(4):417-34.

• 摘要

56.  Gilbert GE, Wahlquist AH, eds. InfoPOEMs: induction of labor may be beneficial at 36 weeks with hypertension. J Natl Med Assoc. 2010;102:151-2.

57.  Chung NA, Beevers G, Lip GY. Management of hypertension in pregnancy. Am J Cardiovasc Drugs. 2001;1(4):253-62.

• 摘要

58.  Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009;122:890-895.

• 摘要

59.  Barton CB, Barton JR, O'Brien JM, et al. Mild gestational hypertension: differences in ethnicity are associated with altered outcomes in women who undergo outpatient treatment. Am J Obstet Gynecol. 2002;186:896-898.

• 摘要

60.  Paridisi G, Biaggi A, Savone R, et al. Cardiovascular risk factors in healthy women with previous gestational hypertension. J Clin Endocrinol Metab. 2006 Apr;91(4):1233-8.

• 全文
• 摘要

61.  Forrester KJ, Barton JR, O'Brien JM, et al. The effect of gestational hypertension and gestational diabetes on neonatal outcome. Obstet Gynecol. 2006;107(suppl 4):26S.

62.  Sep S, Smits L, Prins M, et al. Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review. Hypertens Pregnancy. 2010 Jan;29(2):206-30.

• 摘要

63.  Timpka S, Stuart JJ, Tanz LJ, et al. Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study. BMJ. 2017 Jul 12;358:j3024.

• 全文
• 摘要

64.  Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev. 2005;(4):CD003514.

• 全文
• 摘要